12 West Capital Management LP - ATARA BIOTHERAPEUTICS INC ownership

ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 110 filers reported holding ATARA BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.

Quarter-by-quarter ownership
12 West Capital Management LP ownership history of ATARA BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2020$2,057,000
-11.0%
158,7000.0%0.10%
-16.0%
Q2 2020$2,312,000
+71.1%
158,7000.0%0.12%
+46.9%
Q1 2020$1,351,000
-48.3%
158,7000.0%0.08%
-50.9%
Q4 2019$2,614,000
+16.6%
158,7000.0%0.16%
+14.6%
Q3 2019$2,241,000
-29.8%
158,7000.0%0.14%
-40.0%
Q2 2019$3,191,000
-49.4%
158,7000.0%0.24%
-53.4%
Q1 2019$6,308,000
+14.4%
158,7000.0%0.52%
-9.2%
Q4 2018$5,513,000
-16.0%
158,7000.0%0.57%
+17.6%
Q3 2018$6,562,000
+12.5%
158,7000.0%0.48%
+0.2%
Q2 2018$5,832,000
-16.3%
158,700
-11.2%
0.48%
-37.2%
Q1 2018$6,969,000
-3.4%
178,700
-55.2%
0.77%
-12.2%
Q4 2017$7,216,000
+9.4%
398,7000.0%0.87%
-5.5%
Q3 2017$6,598,000
+18.2%
398,7000.0%0.92%
-2.2%
Q2 2017$5,582,000
-31.9%
398,7000.0%0.94%
-42.1%
Q1 2017$8,193,000
+44.7%
398,7000.0%1.63%
+61.9%
Q4 2016$5,662,000
-33.6%
398,7000.0%1.01%
-17.7%
Q3 2016$8,528,000
-5.0%
398,7000.0%1.22%
-15.5%
Q2 2016$8,975,000
+18.3%
398,7000.0%1.45%
+37.4%
Q1 2016$7,587,000
-27.0%
398,700
+1.3%
1.05%
-29.0%
Q4 2015$10,398,000
+42.7%
393,700
+69.9%
1.48%
+39.6%
Q3 2015$7,285,000231,6971.06%
Other shareholders
ATARA BIOTHERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
KPCB XV Associates, LLC 1,876,650$29,576,00023.33%
Antipodean Advisors LLC 1,000,000$15,760,0006.47%
M28 Capital Management LP 456,865$7,200,0005.62%
Redmile Group, LLC 6,437,777$101,459,0002.31%
One Fin Capital Management LP 303,000$4,775,0001.99%
MAVERICK CAPITAL LTD 7,855,824$123,808,0001.40%
Baupost Group 8,477,488$133,605,0001.32%
BRIDGER MANAGEMENT, LLC 616,488$9,716,0001.26%
683 Capital Management, LLC 1,781,234$28,073,0001.03%
Trellus Management Company, LLC 95,000$1,497,0001.00%
View complete list of ATARA BIOTHERAPEUTICS INC shareholders